Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06950567

Evaluation of the Effectiveness of a Psychoeducational Intervention on Benzodiazepine Use in the Population Over 64 Years Old in Primary Care

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
113 (actual)
Sponsor
Magi Claveria · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

The objective of this pragmatic, multicenter, randomized controlled clinical trial is to determine whether an educational intervention regarding benzodiazepine use can reduce the consumption and/or dosage of these drugs in individuals over 64 years old. It aims to provide knowledge and skills to help participants tolerate or reduce discomfort, enabling them to begin decreasing or discontinuing benzodiazepine (BZD) use. The focus is on the effect of combined care, but the implementation of this approach is also assessed, providing valuable insights for further health developments in Primary Care. Researchers will compare a minimal intervention, consisting of sending a "Benzoletter" to each participant's mailing address, with an intensive intervention that additionally includes psychoeducational sessions and therapeutic exercises. Participants in the intervention group will attend sessions at the Primary Care Center for a total duration of eight weeks.

Conditions

Interventions

TypeNameDescription
OTHERpsycho-educational intervention and therapeutic activityThe objective is to provide knowledge and skills to tolerate/reduce discomfort so that they can begin to reduce or discontinue medication (BZD). The focus is on the effect of combined care, but the implementation of this approach is also evaluated, which will provide valuable knowledge for further health developments in Primary Care.
OTHERControlSending a "Benzocarta" to each person's postal address-a personalized letter signed by their Family Doctor, an explanatory sheet on how to gradually reduce medication, and infographics on sleep hygiene, stress, or anxiety.

Timeline

Start date
2024-04-01
Primary completion
2025-04-01
Completion
2025-05-01
First posted
2025-04-30
Last updated
2025-04-30

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06950567. Inclusion in this directory is not an endorsement.